Regeneron Pharmaceuticals Inc (REGN)
883.20
-7.48
(-0.84%)
USD |
NASDAQ |
Apr 26, 16:00
881.33
-1.87
(-0.21%)
After-Hours: 20:00
Regeneron Pharmaceuticals Price to Book Value: 3.731 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 25, 2024 | 3.764 |
April 24, 2024 | 3.831 |
April 23, 2024 | 3.834 |
April 22, 2024 | 3.804 |
April 19, 2024 | 3.790 |
April 18, 2024 | 3.778 |
April 17, 2024 | 3.808 |
April 16, 2024 | 3.779 |
April 15, 2024 | 3.797 |
April 12, 2024 | 3.823 |
April 11, 2024 | 3.889 |
April 10, 2024 | 3.956 |
April 09, 2024 | 3.989 |
April 08, 2024 | 3.966 |
April 05, 2024 | 3.984 |
April 04, 2024 | 3.960 |
April 03, 2024 | 4.019 |
April 02, 2024 | 4.034 |
April 01, 2024 | 4.096 |
March 28, 2024 | 4.068 |
March 27, 2024 | 4.084 |
March 26, 2024 | 4.072 |
March 25, 2024 | 4.062 |
March 22, 2024 | 4.088 |
March 21, 2024 | 4.091 |
Date | Value |
---|---|
March 20, 2024 | 4.086 |
March 19, 2024 | 4.072 |
March 18, 2024 | 4.057 |
March 15, 2024 | 4.076 |
March 14, 2024 | 4.053 |
March 13, 2024 | 4.080 |
March 12, 2024 | 4.102 |
March 11, 2024 | 4.076 |
March 08, 2024 | 4.094 |
March 07, 2024 | 4.113 |
March 06, 2024 | 4.108 |
March 05, 2024 | 4.079 |
March 04, 2024 | 4.104 |
March 01, 2024 | 4.153 |
February 29, 2024 | 4.083 |
February 28, 2024 | 4.174 |
February 27, 2024 | 4.198 |
February 26, 2024 | 4.181 |
February 23, 2024 | 4.146 |
February 22, 2024 | 4.078 |
February 21, 2024 | 4.027 |
February 20, 2024 | 4.002 |
February 16, 2024 | 4.006 |
February 15, 2024 | 4.035 |
February 14, 2024 | 4.006 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.863
Minimum
Oct 02 2019
7.705
Maximum
Jul 20 2020
4.137
Average
3.808
Median
Apr 25 2022
Price to Book Value Benchmarks
Vertex Pharmaceuticals Inc | 5.839 |
Eli Lilly and Co | 64.73 |
AbbVie Inc | 27.21 |
Bristol-Myers Squibb Co | 3.082 |
Amgen Inc | 23.22 |
Price to Book Value Related Metrics
PE Ratio | 25.41 |
PS Ratio | 7.657 |
Price to Free Cash Flow | 27.38 |
Price | 883.20 |
Earnings Yield | 3.94% |
Market Cap | 96.91B |
Operating PE Ratio | 23.72 |
Normalized PE Ratio | 23.03 |